About Altratech
Altratech is a company based in Clarecastle (Ireland) founded in 2013 by Tim Cummins. It operates as a HealthTech. Altratech has raised $10.98 million across 10 funding rounds from investors including European Commission, Enterprise Ireland and European Union. Altratech offers products and services including Multi-Analyte Point-of-Care Diagnostics. Altratech operates in a competitive market with competitors including NeuMoDx, Kryptos Biotechnologies, Quantalife, Beijing Xinyi Biotechnology and SpinDiag, among others.
- Headquarter Clarecastle, Ireland
- Founders Tim Cummins
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Altratech Ltd
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$10.98 M (USD)
in 10 rounds
-
Latest Funding Round
$11.52 M (USD), Grant
Oct 07, 2024
-
Investors
European Commission
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Altratech
Altratech offers a comprehensive portfolio of products and services, including Multi-Analyte Point-of-Care Diagnostics.
Innovative diagnostics for multiple analytes at point-of-care settings.
People of Altratech
Unlock access to complete
Unlock access to complete
Funding Insights of Altratech
Altratech has successfully raised a total of $10.98M across 10 strategic funding rounds. The most recent funding activity was a Grant round of $11.52 million completed in October 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Altratech
Altratech has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include European Commission, Enterprise Ireland and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward multiple sectors.
|
Locked | Locked | Locked | |
|
VC firm investing in the UK and the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked |
Investor details for Altratech
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Altratech
Investment portfolio details for Altratech
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Altratech
Detailed financials for Altratech
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Altratech Comparisons
Peer comparison for Altratech
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Altratech
Altratech operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuMoDx, Kryptos Biotechnologies, Quantalife, Beijing Xinyi Biotechnology and SpinDiag, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Developer of a platform for low cost molecular testing
|
|
| Locked | Locked | Locked |
Point-of-care molecular diagnostics are enabled by Ultrafast Photonic PCR technology.
|
|
| Locked | Locked | Locked |
Provide tools that accelerate new strategies for the diagnosis and treatment of inherited disorders, cancer, and infectious disease.
|
|
| Locked | Locked | Locked |
Micro-droplet digital PCR and diagnostic reagents are manufactured.
|
|
| Locked | Locked | Locked |
Point-of-care systems for screening drug-resistant pathogens are developed.
|
Detailed competitors of Altratech
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Altratech
Complete news archive for Altratech
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Altratech
Altratech was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Altratech is headquartered in Clarecastle, Ireland. It is registered at Clarecastle, County Clare, Ireland.
Tara Dalton is the current CEO of Altratech.
Altratech is a funded company, having raised a total of $10.98M across 10 funding rounds to date.
Altratech is engaged in developing advanced multi-analyte point-of-care diagnostics. The company operates within the healthcare sector, offering solutions for rapid and accurate medical testing. Its technology is showcased at global conferences like TRI-CON Precision-Medicine in San Diego, aiming to transform diagnostic capabilities for various medical conditions.
Altratech's top competitors include NeuMoDx, ReadyGo and Quantalife.
Altratech offers Multi-Analyte Point-of-Care Diagnostics.
Altratech has 7 investors. Key investors include European Commission, Enterprise Ireland, European Union, Claret Capital Partners, and Kernel Capital.